Comment from Personalized Medicine Coalition

Summary: The Personalized Medicine Coalition (PMC) supports the FDA's draft guidance on using AI for regulatory decision-making, praising its risk-based approach and recognition of AI's potential in personalized medicine. They recommend that the final guidance include specific technical standards for data quality, cybersecurity protections, and international harmonization to ensure safe and equitable AI adoption.